These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35197123)

  • 1. Assessing lead time bias due to mammography screening on estimates of loss in life expectancy.
    Syriopoulou E; Gasparini A; Humphreys K; Andersson TM
    Breast Cancer Res; 2022 Feb; 24(1):15. PubMed ID: 35197123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of lead-time bias in estimates of relative survival for breast cancer.
    Andersson TM; Rutherford MJ; Humphreys K
    Cancer Epidemiol; 2017 Feb; 46():50-56. PubMed ID: 28027488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reference-Adjusted Loss in Life Expectancy for Population-Based Cancer Patient Survival Comparisons-with an Application to Colon Cancer in Sweden.
    Andersson TM; Rutherford MJ; Møller B; Lambert PC; Myklebust TÅ
    Cancer Epidemiol Biomarkers Prev; 2022 Sep; 31(9):1720-1726. PubMed ID: 35700010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A method for evaluating breast cancer screening strategies using screen-preventable loss of life.
    Carter KJ; Castro F; Morcos RN
    PLoS One; 2020; 15(12):e0243113. PubMed ID: 33275605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mammography screening: A major issue in medicine.
    Autier P; Boniol M
    Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study.
    Zahl PH; Gøtzsche PC; Mæhlen J
    Lancet Oncol; 2011 Nov; 12(12):1118-24. PubMed ID: 21996169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefits and Harms of Breast Cancer Screening: A Systematic Review.
    Myers ER; Moorman P; Gierisch JM; Havrilesky LJ; Grimm LJ; Ghate S; Davidson B; Mongtomery RC; Crowley MJ; McCrory DC; Kendrick A; Sanders GD
    JAMA; 2015 Oct; 314(15):1615-34. PubMed ID: 26501537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999-2011.
    Morrell S; Taylor R; Roder D; Robson B; Gregory M; Craig K
    Br J Cancer; 2017 Mar; 116(6):828-839. PubMed ID: 28183141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One-view breast tomosynthesis versus two-view mammography in the Malmö Breast Tomosynthesis Screening Trial (MBTST): a prospective, population-based, diagnostic accuracy study.
    Zackrisson S; Lång K; Rosso A; Johnson K; Dustler M; Förnvik D; Förnvik H; Sartor H; Timberg P; Tingberg A; Andersson I
    Lancet Oncol; 2018 Nov; 19(11):1493-1503. PubMed ID: 30322817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of population-based service screening with mammography for women ages 40 to 49 years with a high or low risk of breast cancer: socioeconomic status, parity, and age at birth of first child.
    Hellquist BN; Czene K; Hjälm A; Nyström L; Jonsson H
    Cancer; 2015 Jan; 121(2):251-8. PubMed ID: 25242087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of breast cancer and estimates of overdiagnosis after the initiation of a population-based mammography screening program.
    Coldman A; Phillips N
    CMAJ; 2013 Jul; 185(10):E492-8. PubMed ID: 23754101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tailored Breast Screening Trial (TBST)].
    Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
    Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss in life expectancy in patients with stage II-III cutaneous melanoma in Sweden: A population-based cohort study.
    Vikström S; Syriopoulou E; Andersson TM; Eriksson H
    J Am Acad Dermatol; 2024 May; 90(5):963-969. PubMed ID: 38218560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Service screening with mammography of women aged 50-69 years in Sweden: effects on mortality from breast cancer.
    Jonsson H; Nyström L; Törnberg S; Lenner P
    J Med Screen; 2001; 8(3):152-60. PubMed ID: 11678556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness evaluation of mammography screening program in Taiwan: Adjusting different distributions of age and calendar year for real world data.
    Lin CN; Lee KT; Chang SM; Wang JD
    J Formos Med Assoc; 2022 Mar; 121(3):633-642. PubMed ID: 34246512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decision-Making Regarding Mammography Screening for Older Women.
    Schonberg MA
    J Am Geriatr Soc; 2016 Dec; 64(12):2413-2418. PubMed ID: 27917463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clarifying the debate on population-based screening for breast cancer with mammography: A systematic review of randomized controlled trials on mammography with Bayesian meta-analysis and causal model.
    Chen TH; Yen AM; Fann JC; Gordon P; Chen SL; Chiu SY; Hsu CY; Chang KJ; Lee WC; Yeoh KG; Saito H; Promthet S; Hamashima C; Maidin A; Robinson F; Zhao LZ
    Medicine (Baltimore); 2017 Jan; 96(3):e5684. PubMed ID: 28099330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous tumour growth models, lead time estimation and length bias in breast cancer screening studies.
    Abrahamsson L; Isheden G; Czene K; Humphreys K
    Stat Methods Med Res; 2020 Feb; 29(2):374-395. PubMed ID: 30854935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Swiss Medical Board Mammography screening predictions for Switzerland: importance of time-periods.
    de Koning HJ; Heijnsdijk EA
    J Med Screen; 2015 Dec; 22(4):201-6. PubMed ID: 26018779
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.